We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,351

PTAB Grants Motion to Amend Claims in an IPR in Valeo v. Schaeffler
  • Haug Partners LLP
  • USA
  • June 23 2017

During an inter partes review (“IPR”) before the Patent Trial and Appeal Board (“PTAB” or “Board”), a patent owner may file a motion to amend the


Supreme Court to Decide the Constitutionality of Inter Partes Review
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • June 22 2017

In a move that could drastically change the patent law landscape, the United States Supreme Court recently granted certiorari in Oil States Energy


Supreme Court Biosimilar Patent Dance Decision Largely Favors Biosimilars
  • Foley & Lardner LLP
  • USA
  • June 13 2017

On June 12, 2017, the Supreme Court issued a unanimous decision in Sandoz Inc. v. Amgen Inc. (No. 15-1039), deciding that 42 U.S.C. 262(l)(9)(C


Differing Burdens of Proof in the PTAB and District Courts can Allow Patent Challengers a Second Bite at the Apple
  • Haynes and Boone LLP
  • USA
  • June 13 2017

The different burdens of proof in the Patent Trial and Appeal Board (PTAB) and in district court means that the PTAB may find patent claims


Different Invalidity Conclusions by PTAB and Federal Courts Prohibited in Inter Partes Reexamination But Permissible in IPR
  • Marshall Gerstein & Borun LLP
  • USA
  • June 6 2017

In Fairchild (Taiwan) Corp. v. Power Integrations, Inc., Appeal 2017-1002 (Fed. Cir. Apr. 21, 2017), the Federal Circuit determined that no inter


Federal Circuit Affirms Different Invalidity Results at PTAB and District Court
  • Knobbe Martens
  • USA
  • June 2 2017

In Novartis AG v. Noven Pharmaceuticals Inc., Appeal Nos. 2016-1678, 2016-1679, the Federal Circuit held that prior judicial opinions concerning the


Inter Partes Re-Examination Estoppel Saves Rejected Claims
  • McDermott Will & Emery
  • USA
  • May 25 2017

Addressing statutory estoppel issues in connection with inter partes re-examination, the US Court of Appeals for the Federal Circuit ordered the


SCOTUS to Decide: Is PTAB Required to Determine Patentability of All Claims Challenged in an IPR Petition?
  • Hunton Andrews Kurth LLP
  • USA
  • May 25 2017

On May 22, 2017, the United States Supreme Court granted certiorari in SAS Institute, Inc. v. Lee, agreeing to decide whether the PTAB is required to


District Court Ruling on Obviousness Does Not Bind PTAB
  • McDermott Will & Emery
  • USA
  • May 25 2017

Addressing issues of motivation to combine and whether the Patent Trial and Appeal Board (PTAB) is bound by district court decisions of obviousness


Federal Circuit Gives PTAB Free Hand on Claim Construction
  • Morgan Lewis & Bockius LLP
  • USA
  • May 24 2017

The Federal Circuit recently held that the Patent Trial and Appeal Board is not constrained by parties’ proposed constructions and may, in fact, adopt